Back to search

Article

Oral Microbiota Associated with Clinical Efficacy of Ustekinumab in Crohn’s disease

2024-08-09

Abstract excerpt

<title>Abstract</title> <p>Crohn’s disease (CD) is a chronic inflammatory gastrointestinal disease. Ustekinumab (UST) has been utilized as a therapeutic option for CD patients. However, approximately 40–60% of patients exhibit an inadequate response to UST. Accumulating evidence has confirmed the involvement of oral bacteria in the development of CD. Nevertheless, the relationship between oral microbiota and the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d1cbfa49-fa58-51fa-bbc9-4dd1f8be1345
DOI
10.21203/rs.3.rs-4705774/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Oral Microbiota Associated with Clinical Efficacy of Ustekinumab in Crohn’s diseaseDOI 10.21203/rs.3.rs-4705774/v1
Select a neighboring publication to make it the new centre.